Records containing: Primary Biliary Cirrhosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-20Exploration of Liver-gut Axis Through Identification of Liver Disease-specific Microbiome
-
CLINICAL_TRIALS study record update · 2026-02-17A Resource of Blood and Other Biospecimens of Patients With Cholestatic Liver Disease and Unaffected Individuals
-
CLINICAL_TRIALS study record update · 2025-12-23ASSURE: An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)
-
CLINICAL_TRIALS study record update · 2025-12-01Repeatability and Reproducibility of Multiparametric MRI (LiverMultiScan)
-
CLINICAL_TRIALS study record update · 2025-09-29Understanding the Genetic Predisposition to the Development of Primary Biliary Cirrhosis (PBC).
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-08-26Usage of TruGraf Liver Gene Expression to Identify Subclinical Rejection as Well as Adjust Immunosuppression Medications in Liver Transplant Recipients Due to Autoimmune Disease
-
CLINICAL_TRIALS study record update · 2025-08-19The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland
-
CLINICAL_TRIALS study record update · 2025-05-29Coordination of Rare Diseases at Sanford
-
CLINICAL_TRIALS study record update · 2024-11-21Randomized Controlled Pilot Study of Highly Active Anti-Retroviral Therapy for Patients With Primary Biliary Cirrhosis
-
CLINICAL_TRIALS study record update · 2024-09-19A Phase 2, Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Magnesium in Patients With Primary Biliary Cholangitis (EPICS )
-
CLINICAL_TRIALS study record update · 2024-09-05A Double-blind, Randomized, Placebo-Controlled Study and Open-label Long Term Extension to Evaluate the Efficacy and Safety of Elafibranor 80 mg in Patients With Primary Biliary Cholangitis With Inadequate Response or Intolerance to Ursodeoxycholic Acid
-
CLINICAL_TRIALS study record update · 2024-06-06Evaluation Safety and Efficacy of Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation for Children Suffering From Liver Cirrhosis Due to Biliary Atresia: A Matched Control Prospective Study
-
CLINICAL_TRIALS study record update · 2024-04-24A Phase 2 Open Label, Proof of Concept Study of HTD1801 (BUDCA) in Adult Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to Standard Therapy - PRONTO-PBC
-
CLINICAL_TRIALS study record update · 2024-03-07An Open Label, Single-Dose, Single Period Study Designed to Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-A4250 in Healthy Male Subjects
-
CLINICAL_TRIALS study record update · 2024-03-07A Phase I, Double-Blind Single and Multiple Ascending Dose Study to Assess Safety and Pharmacokinetics of A4250 as Monotherapy, and in Combination With Colonic Release Cholestyramine (A3384) or Commercially Available Cholestyramine (Questran™) in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2024-01-18Assessing the Feasibility and Acceptability of a 12-week Online Stress Reduction/Wellness Intervention for Primary Biliary Cholangitis: a Pre-post Single-arm Interventional Study
-
CLINICAL_TRIALS study record update · 2023-03-08Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis: a Randomized Control Study
-
CLINICAL_TRIALS study record update · 2022-09-30ClinicalTrials.gov study NCT02823366
-
CLINICAL_TRIALS study record update · 2022-08-12Macrophage Activation Marker sCD163 in PBC Patients - Assessment of Disease Severity and Prognosis
-
CLINICAL_TRIALS study record update · 2022-08-12Measuring Macrophage Activation Markers and Influence on Bile Acid Composition in Patients With Primary Biliary Cholangitis After Treatment With Bezafibrate
-
CLINICAL_TRIALS study record update · 2022-08-12Macrophage Activation Marker sCD163 in PBC Patients - Assessment of Treatment Response to UDCA
-
CLINICAL_TRIALS study record update · 2022-08-03A Randomized Control Trial Evaluating the Impact of a 12-week Mind-body Wellness Intervention in Patients With Primary Biliary Cholangitis (PBC)
-
CLINICAL_TRIALS study record update · 2022-07-14An 8-week, Dose Ranging, Open Label, Randomized, Phase 2 Study With a 44-week Extension, to Evaluate the Safety and Efficacy of MBX-8025 in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or Intolerance to Ursodeoxycholic Acid (UDCA)
-
CLINICAL_TRIALS study record update · 2022-03-31A Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Assess the Efficacy & Safety of Oral GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid and With Persistently Elevated Alkaline Phosphatase
-
CLINICAL_TRIALS study record update · 2021-09-17A Randomized Controlled Clinical Trial on the Efficacy and Safety of Fenofibrate Combined With Ursodeoxycholic Acid in PBC Patients With an Incomplete Biochemical Response to UDCA